Trial Profile
A Randomized, Open-label, Parallel-design Study to Evaluate Pharmacokinetic Drug Interactions and Safety After Coadministration of Clarithromycin, Amoxicillin and Ilaprazole
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jun 2018
Price :
$35
*
At a glance
- Drugs Ilaprazole (Primary) ; Amoxicillin; Clarithromycin
- Indications Gastro-oesophageal reflux; Helicobacter pylori infections; Peptic ulcer; Reflux oesophagitis
- Focus Pharmacokinetics
- Sponsors Il-Yang Pharmaceutical
- 30 May 2018 Results (n=32) assessing pharmacokinetic (PK) drug interaction between clarithromycin, amoxicillin and ilaprazole intended for a triple therapy regimen for eradication of H. pylori, were published in the European Journal of Clinical Pharmacology.
- 24 Mar 2018 Results assessing the pharmacokinetic drug interactions and safety profiles after co-administration of Clarithromycin, Amoxicillin and Ilaprazole, presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 24 Jan 2017 Status changed to completed.